![Evan Lippman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Evan Lippman
Corporate Officer/Principal chez ALNYLAM PHARMACEUTICALS, INC.
Profil
Evan Lippman is currently the Chief Corporate Development & Strategy Officer at Alnylam Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior VP, Chief Financial & Business Officer at Aileron Therapeutics, Inc. from 2015 to 2016.
He also served as the Senior Vice President-Neurodegenerative Diseases at EMD Serono, Inc. and as the President & Chief Operating Officer at Intima Bioscience, Inc. Mr. Lippman completed his undergraduate studies at Bucknell University and Georgia State University.
He holds an MBA from Cornell University.
Postes actifs de Evan Lippman
Sociétés | Poste | Début |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/09/2022 |
Anciens postes connus de Evan Lippman
Sociétés | Poste | Fin |
---|---|---|
AILERON THERAPEUTICS, INC. | Directeur Financier/CFO | 31/12/2016 |
Intima Bioscience, Inc.
![]() Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | President | - |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Formation de Evan Lippman
Bucknell University | Undergraduate Degree |
Georgia State University | Undergraduate Degree |
Cornell University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
![]() Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |